Application 208674
- Type
- ANDA
- Sponsor
- SAGENT PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL; EQ 250MG BASE/VIAL | No | No |
| 002 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | EQ 3GM BASE/VIAL; EQ 375MG BASE/VIAL | No | No |
| 003 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | EQ 4GM BASE/VIAL; EQ 500MG BASE/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 25021-175 | Piperacillin, Tazobactam | Piperacillin Sodium, Tazobactam Sodium | Sagent Pharmaceuticals | ANDA | Current |
| 25021-175 | Piperacillin, Tazobactam | Piperacillin Sodium, Tazobactam Sodium | Sagent Pharmaceuticals | ANDA | Current |
| 25021-176 | Piperacillin, Tazobactam | Piperacillin Sodium, Tazobactam Sodium | Sagent Pharmaceuticals | ANDA | Current |
| 25021-176 | Piperacillin, Tazobactam | Piperacillin Sodium, Tazobactam Sodium | Sagent Pharmaceuticals | ANDA | Current |
| 25021-177 | Piperacillin, Tazobactam | Piperacillin Sodium, Tazobactam Sodium | Sagent Pharmaceuticals | ANDA | Current |
| 25021-177 | Piperacillin, Tazobactam | Piperacillin Sodium, Tazobactam Sodium | Sagent Pharmaceuticals | ANDA | Current |